North China Pharmaceutical (600812.SH): Adolapam tablets with toluene sulfonic acid obtained pharmaceutical registration certificate.
Huabei Pharmaceutical (600812.SH) announced that recently, the company has received the approval and issuance of the Drug Registration Certificate for the edoxaban tosylate tablets (30mg, 60mg) from the National Medical Products Administration. Edoxaban tosylate tablets are oral anticoagulant drugs used for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF) who have one or more risk factors, as well as for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) in adults, to prevent recurrence of DVT and PE.
North China Pharmaceutical (600812.SH) announced that recently, the company has received the approval and issuance of the Drug Registration Certificate for the edoxaban tosylate tablets (30mg, 60mg) by the National Medical Products Administration. Edoxaban tosylate tablets are an oral anticoagulant used for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF) who have one or more risk factors; as well as for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) in adults, and for the prevention of recurrence of DVT and PE.
Related Articles
ETS GROUP (08031) issues 59.12 million shares based on general mandate.
On June 23, TENFU (06868) spent HK$7,880 to buy back 3,000 shares.
Changchun FAWAY Group Automobile Components (600742.SH) has won the bid for the exterior project of a new energy brand customer, with an estimated total sales amount of 704 million yuan.
ETS GROUP (08031) issues 59.12 million shares based on general mandate.
On June 23, TENFU (06868) spent HK$7,880 to buy back 3,000 shares.
Changchun FAWAY Group Automobile Components (600742.SH) has won the bid for the exterior project of a new energy brand customer, with an estimated total sales amount of 704 million yuan.
RECOMMEND
